Evidence map›Paper›PMID 25995098›Full record

ReviewCurrent psychiatry reports2015

Neuromodulation therapies for geriatric depression.

Verònica Gálvez, Kerrie-Anne Ho, Angelo Alonzo, Donel Martin, Duncan George, Colleen K Loo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current psychiatry reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Observational
  11. Psychedelics for Alzheimer's Disease Palliative Care.Advances in psychiatry and behavioral health · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Electroconvulsive Therapy for Geriatric Depression in the COVID-19 Era: Reflection on the Ethics.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2020
    Article
  16. Article
  17. Review
  18. Intervention Research in Late-Life Depression: Challenges and Opportunities.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2016
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Verònica GálvezSchool of Psychiatry, University of New South Wales (UNSW), Hospital Road, 2031, Randwick, Sydney, NSW, Australia.
Kerrie-Anne Ho
Angelo Alonzo
Donel Martin
Duncan George
Colleen K Loo
UNSW Sydney · AUBlack Dog Institute · AUSt. George Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression is frequent in old age and its prognosis is poorer than in younger populations. The use of pharmacological treatments in geriatric depression is limited by specific pharmacodynamic age-related factors that can diminish tolerability and increase the risk of drug interactions. The possibility of modulating cerebral activity using brain stimulation techniques could result in treating geriatric depression more effectively while reducing systemic side effects and medication interactions. This may subsequently improve treatment adherence and overall prognosis in the older patient. Among clinically available neuromodulatory techniques, electroconvulsive therapy (ECT) remains the gold standard for the treatment of severe depression in the elderly. Studies have proven that ECT is more effective and has a faster onset of action than antidepressants in the treatment of severe, unipolar, geriatric depression and that older age is a predictor of rapid ECT response and remission. The application of novel and more tolerable forms of ECT for geriatric depression is currently being examined. Preliminary results suggest that right unilateral ultrabrief ECT (RUL-UB ECT) is a promising intervention, with similar efficacy to brief-pulse ECT and fewer adverse cognitive effects. Overall findings in repetitive transcranial magnetic stimulation (rTMS) suggest that it is a safe intervention in geriatric depression. Higher rTMS stimulation intensity and more treatments may need to be given in the elderly to achieve optimal results. There is no specific data on vagus nerve stimulation in the elderly. Transcranial direct current stimulation, magnetic seizure therapy and deep brain stimulation are currently experimental, and more data from geriatric samples is needed.

Indexed as

Electroconvulsive TherapyTranscranial Direct Current StimulationTranscranial Magnetic StimulationAgedAged, 80 and overCognitionDeep Brain StimulationDepressionHumansMajor Depressive DisorderMemoryMemory DisordersPatient SafetySeizuresTreatment OutcomeVagus Nerve Stimulation

Identifiers

PMID25995098
OpenAlexW225163120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.